Insight Molecular Diagnostics Inc. (IMDX)
NASDAQ · Healthcare
Insight Molecular Diagnostics Inc. Revenue 2020–2025
Insight Molecular Diagnostics Inc. annual/quarterly revenue history and growth rate from 2020 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Insight Molecular Diagnostics Inc. revenue for the quarter ending March 31, 2026 was 32000, a 98.50% decrease year-over-year.
- Insight Molecular Diagnostics Inc. revenue for the twelve months ending March 31, 2026 was 2.9 M, a 257.77% increase year-over-year.
- Insight Molecular Diagnostics Inc. annual revenue for 2025 was 4.1 M, a 115.58% increase from 2024.
- Insight Molecular Diagnostics Inc. annual revenue for 2024 was 1.9 M, a 25.15% increase from 2023.
- Insight Molecular Diagnostics Inc. annual revenue for 2023 was 1.5 M, a 56.89% increase from 2022.
- Insight Molecular Diagnostics Inc. annual revenue for 2022 was 958000.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Insight Molecular Diagnostics Inc. Earnings — FAQ
Insight Molecular Diagnostics Inc. (IMDX) earnings over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see IMDX's earnings history?
The chart and table above show Insight Molecular Diagnostics Inc.'s earnings by year and by quarter, including the growth rate.